APA (7th ed.) Citation

SH, C., TY, T., RC, H., KP, C., CJ, K., YA, L., . . . AC, L. (2026). Longitudinal Monitoring of Pan-Immune-Inflammation Value Forecast Outcomes for Patients with Head and Neck Cancer Treated with Chemoradiotherapy or Radiotherapy: Results from a Large Cohort Study. Biomedicines, 14(4), . https://doi.org/10.3390/biomedicines14040830

Chicago Style (17th ed.) Citation

SH, Chen, et al. "Longitudinal Monitoring of Pan-Immune-Inflammation Value Forecast Outcomes for Patients with Head and Neck Cancer Treated with Chemoradiotherapy or Radiotherapy: Results from a Large Cohort Study." Biomedicines 14, no. 4 (2026). https://doi.org/10.3390/biomedicines14040830.

MLA (9th ed.) Citation

SH, Chen, et al. "Longitudinal Monitoring of Pan-Immune-Inflammation Value Forecast Outcomes for Patients with Head and Neck Cancer Treated with Chemoradiotherapy or Radiotherapy: Results from a Large Cohort Study." Biomedicines, vol. 14, no. 4, 2026, https://doi.org/10.3390/biomedicines14040830.